Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Alphapharm Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (849)
Cancellation by sponsor (780)
Prescription medicine registration (54)
Cancellation or suspension (44)
Australian Public Assessment Report (AusPAR) (3)
Designation or determination (3)
Prescription medicine decision summary (2)
Section 14, TGO91 consent (1)

Date

2024 (18)
2023 (84)
2022 (230)
2021 (265)
2020 (113)
2019 (35)
2018 (66)
2017 (364)
2016 (34)
2015 (22)
2014 (48)
2013 (40)
2012 (61)
2011 (28)
2010 (46)
2009 (25)
2008 (10)
2007 (28)
2006 (6)
2005 (17)
2004 (15)
2003 (33)
2002 (15)
2001 (4)
2000 (14)
1999 (9)
1998 (8)
1997 (11)
1996 (10)
1995 (7)
1994 (6)
1993 (12)
1992 (11)
1991 (41)

Results for "[search-keyword]"

Search

Sponsor content

1736 result(s) found, displaying 521 to 530

AYLIDE 1 Glimepiride 1 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2021

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
QPRIL 40 quinapril 40mg (as hydrochloride) tablet blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2021

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
PAMACID 20 famotidine 20mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2021

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
PAMACID 40 famotidine 40mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2021

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
TILODENE ticlopidine hydrochloride 250mg tablet bottle Cancelled under Section 30(1)(c) of the Act

24 June 2021

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
ACRIS COMBI risedronate sodium 35 mg tablets and calcium carbonate 1250 mg tablets blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2021

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
CODAGESIC tablet blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2021

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
SELGENE selegiline hydrochloride 5mg tablet bottle Cancelled under Section 30(1)(c) of the Act

24 June 2021

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
CORBETON 40 Oxprenolol hydrochloride 40mg tablet bottle Cancelled under Section 30(1)(c) of the Act

24 June 2021

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
CODAPANE tablet blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2021

Cancellation by sponsor

Requested by Alphapharm Pty Ltd

Pages

First page
Previous page
…
Page 49
Page 50
Page 51
Page 52
Current page 53
Page 54
Page 55
Page 56
Page 57
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.